Yumi Watanabe Selected Research

Yumi Watanabe Research Topics

Disease

8	Cognitive Dysfunction 01/2023 - 01/2016
5	Neoplasms (Cancer) 11/2021 - 02/2004
4	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2017
3	Schizophrenia (Dementia Praecox) 03/2024 - 10/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2019
3	Body Weight (Weight, Body) 01/2018 - 01/2017
3	Hemorrhage 12/2014 - 12/2011
2	Tardive Dyskinesia 03/2024 - 11/2022
2	Dementia (Dementias) 10/2023 - 12/2021
2	Stroke (Strokes) 11/2021 - 05/2016
2	Myocardial Infarction 11/2021 - 05/2016
2	Acidosis 06/2021 - 07/2019
2	Catalepsy 01/2020 - 10/2019
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2013 - 06/2007
2	Adenocarcinoma 12/2008 - 02/2008
2	Vomiting 06/2008 - 01/2008
1	Psychotic Disorders (Schizoaffective Disorder) 03/2024
1	Dyskinesias (Dyskinesia) 03/2024
1	Mental Disorders (Mental Disorder) 03/2024
1	Depressive Disorder (Melancholia) 03/2024
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2024
1	Pelizaeus-Merzbacher Disease 10/2022
1	Neurologic Manifestations (Neurological Manifestations) 10/2022
1	Pain (Aches) 10/2022
1	Osteoporosis 01/2021
1	Osteoporotic Fractures 01/2021
1	Chronic Pain 01/2018
1	Erectile Dysfunction 01/2018
1	Hemorrhagic Shock 12/2011
1	Melanoma (Melanoma, Malignant) 01/2011
1	Brain Injuries (Brain Injury) 01/2010
1	Hepatocellular Carcinoma (Hepatoma) 06/2008

Drug/Important Bio-Agent (IBA)

6	ORALIT (ORS)IBA 01/2021 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2017
4	CanagliflozinIBA 01/2018 - 01/2017
3	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2018 - 01/2017
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018 - 01/2017
3	RetinoidsIBA 12/2008 - 02/2008
2	valbenazineIBA 03/2024 - 11/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2011
2	ProteomeIBA 01/2023 - 01/2019
2	TeaIBA 12/2021 - 05/2016
2	EnzymesIBA 09/2020 - 01/2013
2	ProlactinIBA 01/2020 - 10/2019
2	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 10/2019
2	SodiumIBA 01/2018 - 01/2017
2	SymportersIBA 01/2018 - 01/2017
2	Neuroprotective AgentsIBA 01/2010 - 06/2007
2	T-2328IBA 06/2008 - 01/2008
2	Messenger RNA (mRNA)IBA 02/2008 - 11/2005
1	Ethanol (Ethyl Alcohol)IBA 10/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2022
1	Coffee FDA Link 12/2021
1	Caffeine (No Doz)FDA LinkGeneric 12/2021
1	LipopolysaccharidesIBA 06/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Vitamin K FDA Link 01/2021
1	Dietary CalciumIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	ImmunosorbentsIBA 09/2020
1	AD 5IBA 09/2020
1	ApolipoproteinsIBA 09/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020
1	MT-3014IBA 01/2020
1	Olanzapine (Zyprexa)FDA Link 10/2019
1	AminesIBA 10/2019
1	PyransIBA 10/2019
1	Haloperidol (Haldol)FDA LinkGeneric 10/2019
1	Bacterial DNAIBA 07/2019
1	Fumigant 93 (D-D)IBA 07/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2019
1	Butyric Acid (Butanoic Acid)IBA 07/2019
1	Phosphodiesterase 5 InhibitorsIBA 01/2018
1	avanafilIBA 01/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2018
1	HDL CholesterolIBA 01/2018
1	C-PeptideIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 12/2014
1	Chondroitin ABC LyaseIBA 01/2013
1	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 12/2011
1	Urethane (Ethyl Carbamate)IBA 12/2011
1	TA 0910IBA 12/2011
1	prolinamideIBA 12/2011
1	VaccinesIBA 01/2011
1	CalciumIBA 12/2008
1	ThioredoxinsIBA 12/2008
1	Carrier Proteins (Binding Protein)IBA 12/2008
1	Cisplatin (Platino)FDA LinkGeneric 06/2008
1	TachykininsIBA 06/2008

Therapy/Procedure

5	Therapeutics 03/2024 - 11/2012
1	Conduction Anesthesia (Regional Anesthesia) 10/2022
1	Analgesia 10/2022
1	Epidural Anesthesia 10/2022
1	Epidural Analgesia 10/2022
1	Activities of Daily Living (ADL) 11/2021
1	Intravenous Administration 12/2011
1	Transplantation 01/2010